Longitude Capital is a California-based venture capital firm specializing in investments in biotechnology, medical technology, and health solutions companies. Founded in 2006, the firm has raised over $2 billion across six funds, demonstrating its ability to source, manage, and exit attractive investments across multiple market cycles. Longitude Capital focuses on investments that can deliver key value-creating milestones and attractive venture returns within three to five years from the investment date.

The firm's investment strategy is flexible, allowing for investments across all stages of a company's life cycle in both publicly traded and privately held companies, as well as in special situations like spin-outs, recapitalizations, and certain public company structures. Longitude Capital also conducts extensive proprietary thematic research to proactively analyze sectors, therapeutic areas, and technologies of interest to support its investment strategy. The firm's name was inspired by the Longitude Prize, a competition established by the British monarchy in 1714 to solve one of the greatest scientific problems of the day.